Instead, no clear results are available at moment about the chemo-adjuvant potential of the same therapeutic strategies in PDAC
GLP-1-class receptor effects on satiety wane rapidly without continued dosing
Just like all medications, semaglutide may cause side effects
Furthermore, although glucose control remains a central objective, it should be managed in the context of a comprehensive cardiovascular (CV) risk factor reduction programme, including smoking cessation, blood pressure control, lipid management and antiplatelet therapy [1]
MRPs are also effective delivery systems to enhance stability and bioavailability of several dietary compounds
Clinical Pearl: Monitor Sodium During Glucose Loading When administering 300400 g of IV glucose daily for a mild acute porphyria attack, serum sodium and fluid status require close monitoring